Furthermore, it should be noted that JAK/STAT pathway inhibitors have been associated with neurotoxicity, including dizziness and peripheral neuropathy, with momelotinib being linked to peripheral neuropathy [21, 22]. The gene discussed is SOAT1; the disease is peripheral neuropathy.